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Abstract 
 
Objectives: Thoracic aortic aneurysms (TAAs) affect 10 per 100,000 people, and are 
responsible for significant mortality. Open surgical repair carries substantial risks of both 
morbidity and mortality. Endovascular TAA repair is a relatively new technology, with 
numerous proposed benefits over open repair. However, data is yet to demonstrate 
whether endovascular TAA repairs outperform open repair. We sought to observe trends 
and outcomes of TAA repairs over the previous decade in order to identify the optimal 
method of management of thoracic and thoracoabdominal aneurysm repairs, as well as 
predictors of poor outcome. 
Methods: We conducted a retrospective analysis of all patients presenting for management 
of thoracic and/or aortic (ruptured and non-ruptured) from 2003-2013, at two tertiary-level, 
acute care hospitals in Sydney, Australia.  
Results: 179 patients presented with thoracic or thoracoabdominal aneurysms, 127 of 
whom were treated surgically, and five of whom presented with aneurysmal rupture. The 52 
patients managed non-operatively were more likely to be older, and more likely to be 
female. Of the patients managed surgically, 69 had ascending aneurysms, 27 had arch 
aneurysms, and 31 descending TAAs.  Thirty-one patients underwent repair of descending 
TAAs, 12 open and 19 endovascular. Patients undergoing endovascular repair of descending 
TAAs were significantly older than those undergoing open repair. Operative duration was 
significantly shorter for endovascular than open repair of arch and descending aneurysms. 
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There were no differences in morbidity or mortality, duration of hospitalisation, or 
transfusion requirement between the groups.  
Patients over 75 years of age with arch aneurysms were more likely to develop an endoleak 
or return to theatre than those under 75. Similarly, patients over 75 years undergoing 
descending aneurysm repair were twice as likely to have an endovascular repair, required 
more blood transfused, and have a longer ICU and total hospital stay. Otherwise, there were 
no predictors for poor outcome post-TAA repairs. There was a trend for increasing 
endovascular repair of descending aneurysms, but no change in morbidity or mortality over 
time. 
Conclusion: Overall mortality was low during the study period, but morbidity after open or 
endovascular thoracic or thoracoabdominal aneurysm repair remains substantial. Apart 
from reducing surgical duration, endovascular repair demonstrated no additional benefits 
over open TAA repair. Patients over the age of seventy-five were more likely to suffer 
adverse events than those under seventy-five. However, the current study demonstrated 
that either open or endovascular TAA repair can be performed with low morbidity and 
mortality, even in elderly patients. 
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Introduction 
 
Background 
 
The thoracic aorta is usually 2.5-3cm in diameter depending on sex and body habitus1. An 
aneurysm is defined as a greater than fifty percent dilatation of an endothelium-lined 
vascular structure, thus the thoracic aorta is aneurysmal once it reaches 4.5cm. Thoracic 
aortic aneurysms (TAAs) include aneurysms involving the ascending aorta (from the aortic 
annulus to the brachiocephalic trunk), the aortic arch (brachiocephalic trunk to the left 
subclavian), and the descending aorta (including thoracoabdominal aneurysms, extending 
from proximal to the left subclavian artery to as far as the infra-renal aorta; see Figure A)2. 
 
Ascending aneurysms account for fifty percent of TAAs, the arch ten percent, and forty 
percent involve the descending aorta (of which one quarter extend distal to the 
diaphragm)3. TAAs are three to seven times less common than abdominal aortic aneurysms 
(AAA)4 but still carry a significant burden of disease, with an incidence of 10 per 100,000 
people1. TAAs affect males twice as frequently as females, with the mean age of TAA repair 
being 67 years5.  
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Figure A – Crawford Classification of thoracoabdominal aneurysms. From Azizzedeh et al4 
 
Factors commonly predisposing to thoracic aneurysm development include hypertension, 
smoking and chronic obstructive pulmonary disease1. As such, eighty percent of TAAs are 
defined as being of ‘degenerative’ aetiology, with the relationship of degenerative 
aneurysms and atherosclerosis discussed below6. In fifteen to twenty percent of TAAs, 
genetic syndromes predispose to thoracic aortic aneurysms7,8. These syndromes include 
Marfan’s, Loeys-Dietz, and Ehlers-Danlos syndromes, and predispose to aneurysmal change 
due firstly to chronic aortic dissection, and secondary to dilatation of the wall of the false 
lumen6. Inflammatory vasculitidies, such as giant cell arteritis, Takayasu arteritis and 
Rheumatoid arthritis, are responsible for two percent of TAAs6,9. Infective aetiologies are 
even less common, with pathogens including Salmonella and Staphylococcal species, with 
syphilitic and tuberculous aneurysms less common still6,9. 
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Histopathological changes occurring in the wall of aneurysmal thoracic aortic tissue, 
triggered by the aforementioned predisposing factors, culminate in medial degeneration 
(previously called cystic medial necrosis6,10). This is characterised by fragmentation of elastic 
tissue, loss of smooth muscle cells, and accumulation of ground substance within the medial 
layer of the aortic wall10. While more common in elderly patients, medial degeneration is 
accelerated by hypertension and atherosclerosis6. Pathogenesis of medial degeneration 
involves over-expression and over-activation of proteinases (namely the matrix 
metalloproteinase family, especially matrix metalloproteinase 911), as well as alterations in 
transforming growth factor beta (TGF-β) function12 and infiltration by activated T cells and 
macrophages10, resulting in degradation of the extracellular matrix, and aneurysmal 
expansion. Aneurysms are described as being either fusiform (a uniform dilatation of the 
entire aortic circumference, which is more common), or saccular (a localised dilatation of 
one part of the aortic wall). Saccular aneurysms require more vigilant follow up, as they are 
more likely to require repair than fusiform aneurysms13.  
 
Ninety-five percent of thoracic aortic aneurysms are asymptomatic14, with the remaining 
five percent presenting with non-specific symptoms including chest, back, abdominal or 
flank pain, or symptoms from local compression of the recurrent laryngeal nerve, trachea, 
or oesophagus6. Symptomatic patients are more likely to have an aneurysm diameter of 
greater than 5 centimetres6. There is little to be found on clinical examination, and 
computed tomography or magnetic-resonance angiography are investigations of choice1. 
Medical therapy includes smoking cessation and beta-blockade to reduce shear stress, with 
debate currently regarding the efficacy of statins and angiotensin-converting-enzyme 
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inhibitors for reduction in oxidative stress15. Without surgical intervention, the two-year 
mortality rate is as high as forty-seven percent in patients unfit for surgery16, due to rupture 
and rapid exsanguination.  
 
5 
 
Surgical Management of Thoracic and Thoracoabdominal Aneurysms 
 
Surgical management of thoracic aortic aneurysms was first described in 195517, in which 
Etheredge  used a homograft (a vascular conduit from the same patient) to replace the 
resected aneurysm. Current guidelines from the American College of Cardiology Task Force 
recommend repair of ascending aortic aneurysms only when maximal external diameter 
reaches 5.0cm, arch repairs at 5.5cm, descending repairs at 5.5cm, or a rapid rate of annual 
expansion on surveillance1.  
 
Open repair of thoracoabdominal aneurysms involves positioning the patient in the lateral 
decubitus position with left side up, and exposure is obtained via an incision in the fourth to 
eighth intercostal space extended to the midline, with the laparotomy continued inferiorly. 
The retroperitoneum is then accessed, and the diaphragm divided. Cardiopulmonary bypass 
may be required, dependent on proximal extent of aorta involved, and induced 
hypothermia may be considered. After systemic heparinisation, the aorta is cross-clamped, 
with the level of proximal clamp dependent on extent of the aneurysm. The proximal aorta 
is anastamosed to the proximal graft, followed by reimplantation of visceral and renal 
vessels. Intercostal artery reimplantation may be performed, dependent on pre-operative 
imaging, or changes in motor-evoked potentials in the lower limbs during the operative 
period. After the distal anastamosis is completed and the wound closed, the patient is 
monitored in the intensive care unit6. 
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Although vast improvements in operative technique and peri-operative care (namely 
anaesthetic and intensive care) have been made since 1955, morbidity and mortality 
remains high18.  A 2006 study showed 19% perioperative mortality, and a one-year mortality 
of thirty-one percent18. A recent multi-centre study in France demonstrated that hybrid 
procedures (open vascular reimplantation simultaneously with endograft repair) are 
associated with a post-operative mortality of 34%, due to the invasive nature of the 
procedure and poor patient selection19. Substantial morbidity in TAA repairs is also 
common.  Arterial supply of the spinal cord is partly via radicular arteries, which arise from 
the intercostal and lumbar branches of the aorta. Interruption of this arterial supply (due to 
insertion of stent-grafts during either open or endovascular TAA repair) risks spinal cord 
ischemia (SCI) and subsequent paraplegia, a complication which occurs in between five and 
twenty-one percent of TAA repairs20. Visceral ischemia is also a common phenomenon, with 
post-operative renal failure occurring in up to eight percent of patients21. Cardiorespiratory 
complications are also commonly experienced (such as acute coronary syndromes and lower 
respiratory tract infections)22,23. As a result, TAA repair remains a high-risk endeavour, with 
further improvements in technique and patient selection needed. 
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Endovascular Repair of Thoracoabdominal Aneurysms 
 
The first endovascular intervention for the treatment of vascular pathologies was described 
by Seldinger in 195324, and further developed by Dotter in 196325. It is now accepted as the 
optimal method of management for many vascular diseases, including AAA, peripheral 
vascular disease and chronic gastrointestinal ischemia26-29. The benefits of endovascular 
interventions include their minimally invasive natures which results in reduced blood loss 
and a lower risk of infection, reduced procedure time and transfusion requirement, reduced 
duration of mechanical ventilation, low operative morbidity and mortality, reduced cost, 
reduced intensive care unit stay, and faster time to mobilisation and discharge from 
hospital27,30-32. In addition to these general advantages, proposed benefits of endovascular 
repair specific to TAA include avoidance of the physiological insults of aortic cross-clamping 
and thoracic or thoracoabdominal incisions in these often frail patients20. Additionally, 
ability to utilise local anaesthesia in up to 53% of patients33 allows avoidance of 
cardiorespiratory morbidity and mortality associated with general anaesthesia, as well as 
reduced hospital stay34. However, endovascular interventions have their own limitations. 
Endovascular repair can be precluded by poor femoral access (see below), tortuous or 
occluded iliac vessels preventing placement of the device into the thoracic aorta, or 
contraindications to iodinated contrast media (including renal failure and anaphylaxis). 
Further, at least two centimetres of healthy aorta is required as a landing zone (the space 
needed to anchor the proximal and distal ends of the graft, without covering branches of 
the aorta), which may be absent in extensive aneurysms. 
 
8 
 
To undertake an endovascular repair of a TAA, the chosen common femoral artery (CFA) is 
accessed either percutaneously via Seldinger technique or via femoral cutdown, and a 
guidewire placed into the ascending aorta. A marking pigtail catheter is likewise inserted via 
the contralateral CFA. Angiography is used to confirm landing zones, and the covered stent-
graft is deployed over the guidewire. Fenestrated endografts are an increasingly used 
technology, which allow separate stents to be deployed through holes in the endograft to 
the renal and mesenteric arteries to maintain perfusion to these organs if their position 
precludes a sufficient landing zone (and would otherwise have been covered by the stent)5. 
While these are generally custom made, in situ fenestration is increasingly being performed 
after graft deployment, with cutting balloons35, and radiofrequency puncture36. Closure is 
percutaneously via a closure device, or oversewing the arteriotomy in the CFA6.  
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Open Versus Endovascular Thoracoabdominal Aneurysm Repair 
 
When comparing open and endovascular thoracoabdominal aneurysm repairs in terms of 
major endpoints such as mortality, data is conflicted. The largest study to date was 
conducted by Greenberg et al on 724 patient records and demonstrated no difference in 
mortality either at one month or one year5, findings echoed by a Swiss study which saw no 
difference at one, 12, 24 or 36 months37. Similarly, a study of US Medicare data between 
1998 and 2007 demonstrated that while in the short term patients undergoing endovascular 
repair were less likely to die (6.1 vs 7.1%, p = 0.07), this is lost by two years38. Several 
smaller studies agree, finding that a mild perioperative survival benefit is quickly lost, and 
remains absent at up to 10 years39-43. Overall, evidence suggests no difference in long term 
mortality between endovascular and open TAA repairs. The benefits of either technique in 
minimising spinal cord ischemia also has not been definitely proven, with only one study of 
84 patients demonstrating a reduced risk of SCI5,39-41,44,45.  
 
Endovascular approaches have generally been shown to decrease the incidence of 
renal39,41,42 and respiratory failure39, the duration of ICU41,42,45 and hospital stays39,45, and 
rates of reoperation5,42.  There is however evidence for an increased incidence of 
endoleaks39, peripheral vascular complications39, and increased cost41,42 with endovascular 
interventions. Interestingly, patients who underwent endovascular TAA repair reported 
being significantly more depressed, and scored lower than a healthy cohort on subjective 
physical and mental domain scores, while the open repair group scored within the normal 
range37.  
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The difficulty with comparative studies is the fact that sicker and older patients are more 
likely to receive endovascular TAA repair5,37,40,41, thus skewing outcomes. A large meta-
regression by Cheng et al (which included traumatic aneurysm repairs) demonstrated that 
age did not impact outcomes when considering mortality, cerebrovascular accidents and 
paraplegia46. The 5,888 patients in this study demonstrated endovascular TAA repair to be 
superior in perioperative mortality, paraplegia, cardiac and respiratory complications, renal 
dysfunction, and need for transfusion. However, there were no differences in rates of 
stroke, acute coronary syndromes or mortality beyond 12 months when comparing the two 
techniques. 
 
While the number of open TAA repair has remained stable in the United States, the 
incidence of endovascular TAA repairs has increased from zero to thirty-three percent43. 
This can be attributed to the increasing acceptability of endovascular approaches, as well as 
the aging population making minimally invasive techniques more attractive, especially in 
high risk patients33. However, neither open nor endovascular TAA repair has been shown to 
be the optimal method of management of this condition, which continues to carry 
significant morbidity and mortality.  
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Rationale for the Study 
 
To date, few studies have directly compared the benefits of endovascular and open TAA 
repair5,37,39-42,44.  While some studies are prospective, there are at the time of writing no 
randomised controlled trials47. Only two studies have examined data later than 2007, and 
there are no studies with data more recent than 2010, despite the rapid change in 
endovascular technology over the last decade. These studies also tend to examine data from 
single centres, with small sample sizes. The current body of knowledge is limited in that the 
control group of one of the notable prospective trials39 has a large part of their open surgical 
cohort comprised of historical controls, a factor likely to impact both patient selection and 
cause confounding of other factors. No studies to date have been performed in Australia, 
and the relative prevalence of endovascular TAA repairs in Australia is unknown. Further, 
some of the published studies group thoracic and thoracoabdominal aneurysms together41, 
limiting the application of these results to TAA repairs specifically. This study will be one of 
the largest studies of its kind to date internationally, one of the first studies assessing 
patients across more than one centre, and be the first undertaken in an Australian setting. 
 
Thoracic aortic aneurysms are responsible for a significant mortality if left untreated, and 
surgical repair itself can comprise a substantial burden of morbidity and mortality. Equipoise 
remains in the question of open versus endovascular management of thoracic and 
thoracoabdominal aneurysms, and ascertaining the optimal the optimal management of this 
pathology is essential. A study is required that examines patients from more than one local 
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clinical centre, using data that is recent, with contemporaneous open and endovascular 
groups. Such a study should also examine arch and descending aneurysms separately. 
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Aim of the Study 
 
This study was proposed to compare morbidity, mortality, clinical outcomes and trends over 
time of open and endovascular repair of thoracic aortic aneurysms in Australia. The findings 
will compare the clinical outcomes of open and endovascular TAA repairs in two large 
hospitals. We also seek to assess the impact of age on outcomes. The study will illustrate 
the clinical feasibility of the two techniques, demonstrating the optimal method of 
management of TAAs, as well as illustrating improvements in management of this condition 
over time, and providing direction for future service planning in Australia. 
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Hypothesis 
 
Our primary hypothesis is that endovascular thoracic and thoracoabdominal aneurysm 
repair will outperform open repair in regards to mortality. Secondary hypotheses are that 
endovascular repair would similarly demonstrate superiority regarding complication rate, 
duration of hospital stay and transfusion requirement over open repair. Additionally, we 
hypothesised that mortality has decreased over time in all patients undergoing surgical 
intervention. 
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Limitations 
 
Potential limitations of this study include its retrospective nature, and the potential of 
complications of either open or endovascular techniques to be remedied at other 
institutions (namely after discharge), thus being missed by the data collection methods of 
the current study. These include (but are not limited to) endoleaks, wound infection and 
dehiscence, other infective complications and thromboembolic complications. Further, due 
to the short duration of follow-up, the not insignificant risk of endoleak after endovascular 
repair48 will not be captured, and therefore this ‘Achilles heel’ of endovascular aneurysm 
was not considered in the current study.  
As patients not suitable for a large open operation are often selected for endovascular 
repair, it is possible that patients that undergo endovascular repair will possess more 
surgical risk factors as previously described5, which may interfere with outcome analysis.  
Further, as there are anatomical contraindications to endovascular repair (both patient and 
aneurysm morphology), clinicians will select patients for one or other procedure, so 
selection bias cannot be excluded. In addition, the small numbers, and significant 
heterogeneity between cases mean that careful consideration must be given when 
extrapolating these results. 
Lastly, comparisons between surgeons and hospitals were not undertaken. While these are 
potential sources of variability, this study aimed to compare the two surgical techniques, 
rather than compare outcomes between institutions. 
16 
 
Study Design 
 
Study Questions 
 
The aim of the current study was to compare morbidity, mortality, clinical outcomes and 
trends over time of open and endovascular repair of thoracic aortic aneurysms in Australia.  
 
The three specific research questions were: 
1) Is there a significant difference in in-hospital mortality between open and 
endovascular thoracic aortic aneurysm repairs? 
2) Are there significant differences in complication rates and use of hospital resources 
between the two procedures? 
3) Have mortality rates of patients undergoing TAA repair decreased over the previous 
decade? 
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Patient Selection & Data Collection 
 
In order to investigate these hypotheses, a study comparing these two techniques was 
designed. A retrospective analysis of patient records was conducted at two acute-care 
hospitals located in Sydney, Australia. Royal Prince Alfred Hospital and St George Hospital 
are both tertiary level hospitals in metropolitan Sydney with twenty-four hour 
cardiothoracic and vascular surgery services, with 911 and 547 beds respectively. 
To observe patterns over the preceding decade, all patients who presented with thoracic 
aortic aneurysms (ruptured and un-ruptured) between January 2003 and January 2013 
(inclusive) were included. This was achieved by using International Classification of Diseases 
10 classifications I71.1 (thoracic aortic aneurysm, ruptured), I71.2 (thoracic aortic aneurysm, 
without mention of rupture), I71.5 (thoracoabdominal aneurysm, ruptured) and I71.6 
(thoracoabdominal aortic aneurysm, without mention of rupture) were used to identify 
patients who presented with thoracic aortic aneurysms (including descending aneurysms of 
Crawford Class 0-III. 
 
Various demographic, surgical and clinical variables were collected. Independent variables 
were collected in order to firstly observe the demographics of the study population, and 
secondly to control for confounders. They included age, sex, year of intervention, aneurysm 
type (including Crawford class for descending aneurysms) and size, co-morbidities, American 
Society of Anaesthesiologists (ASA) score, presence of rupture, use of local or general 
anaesthetic, open or endovascular intervention, type and brand of graft, use of cardio-
pulmonary bypass, and use of cerebrospinal fluid (CSF) drainage. Outcome variables (used 
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to compare groups) included duration of surgical procedure, number of units of blood 
transfused, in-hospital complications, post-operative paraplegia (as described below), in-
hospital mortality, presence of endoleaks, rates of return to theatre (within 24 hours) and 
re-operation (after the first 24 hours), acute kidney injury (defined as an increase in serum 
creatinine greater than fifty percent49) and acute kidney failure (defined as a tripling of 
serum creatinine49), time to first mobilisation, and duration of hospital and ICU (including 
coronary care unit) stay.  
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Paraplegia and paraparesis were defined as follows: 
Category and Score Description 
Paraplegia 
0 
1 
2 
 
Nil Movement 
Minimal motion 
Motion, but not against resistance/gravity 
Paraparesis 
3 
4 
 
Motion against resistance/gravity only 
Able to mobilise with assistance 
 
TABLE 1- SCORING SYSTEM FOR PARAPLEGIA/PARAPARESIS POST TAA REPAIR. MODIFIED FROM GREENBERG ET AL 20085 
 
Patients were divided into two age groups (over and under the age of seventy-five years) to 
compare outcomes between younger and more elderly patients. Seventy-five years was 
chosen as this has been previously found to be the median age of a high risk TAA-repair 
population16. Cook Medical® provided a research scholarship for two research assistants 
(medical students) who, after ethics approval was gained, were taught to interpret the 
medical records, and enter data into a de-identified spread-sheet. They were not told the 
source of the funding until after the data were collected, in order to reduce the risk of bias. 
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Statistical Analysis 
 
Mann-Whitney U tests were used to assess differences between the medians of groups for 
continuous variables with skewed distributions, while T-tests were used to compare means. 
Categorical variables were compared using Pearson Chi-squared Tests. Binomial tests were 
used to compare observed frequencies. Linear regression was used to assess the 
relationship between independent and outcome variables, and changes in rates of repair, 
and morbidity and mortality over time. A p value of 0.05 was considered to be statistically 
significant. All analyses were performed using SPSS 22 (IBM, New York, New York, United 
States). 
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Abstract 
 
Thoracic aortic aneurysms (TAAs) contribute significant mortality if left untreated, but 
surgical repair has historically carried substantial risks. We sought to observe trends and 
outcomes of thoracic aortic repairs, so conducted a retrospective review of all patients who 
presented for management of TAAs from 2003 to 2013 at two hospitals in Sydney, Australia. 
179 patients presented with TAAs over the study period, including 5 ruptures. 52 were 
treated non-operatively, with 127 surgically repaired. Operative duration was significantly 
shorter in endovascular than open repair of arch (193 ± 108 vs 396 ± 98 minutes, p = 0.0001) 
and descending aneurysms (242 ± 116 vs 422.5 ± 161 minutes, p = 0.003). There were no 
differences in mortality or complication rates (including paraplegia), duration of hospital or 
ICU stay, or transfusion requirements between endovascular and open TAA repairs. Apart 
from reduced surgical duration, this study revealed no benefits of endovascular over open 
TAA repair. Overall morbidity and mortality was low, even in elderly patients. 
 
Key words: thoracic aneurysm repair, open, endovascular, mortality 
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 Introduction 
 
Thoracic aortic aneurysms (TAAs) include aneurysms involving the ascending aorta (from the 
aortic annulus to the brachiocephalic trunk), the aortic arch (the brachiocephalic trunk to 
the left subclavian), and the descending aorta (including thoracoabdominal aneurysms, 
extending from the left subclavian artery to the infra-renal aorta1). Ascending aneurysms 
account for sixty percent of TAAs, the arch ten percent, and the descending aorta thirty 
percent (of which one quarter extend distal to the diaphragm2).  TAAs have an incidence of 
10 per 100,0003, and if untreated carry a significant burden of disease, with a five-year 
survival of fifty-four percent4, and up to a forty-seven percent two year mortality in high risk 
patients5. 
 
Although vast improvements have been made since the first surgical repair of a TAA in 
19556, perioperative mortality remains as high as nineteen percent, with one-year mortality 
of up to thirty-one percent7. Further, a recent study demonstrated mortality to be as high as 
thirty-four percent in the post-operative period post hybrid TAA repair (open vascular 
reimplantation simultaneously with endograft repair)8. Substantial morbidity is also 
common. Interruption of spinal arterial supply runs the risk of spinal cord ischemia (SCI) and 
subsequent paraplegia, while renal ischemia risks acute kidney injury and failure. Each of 
these complications can occur in up to eight percent of TAA repairs9-11. Cardiorespiratory 
complications are also commonly experienced12, 13. As a result, TAA repair remains a high-
risk endeavour. 
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Endovascular repair is accepted as the optimal method of management for many vascular 
diseases14-17. Reported benefits include reduced blood loss and infection risk, reduced 
procedure time and transfusion requirement, reduced duration of mechanical ventilation, 
low operative morbidity and mortality, reduced cost, reduced intensive care unit stay, and 
faster time to mobilisation and discharge from hospital17-20. In addition to these general 
advantages, proposed benefits of endovascular repair specific to TAAs include avoidance of 
the physiological insults of aortic cross-clamping and thoracic or thoracoabdominal 
incisions11. Ability to utilise local anaesthesia in up to fifty-three percent of patients 21 
allows avoidance of cardiorespiratory morbidity and mortality associated with general 
anaesthesia, as well as reduced hospital stay. 
 
To date, apart from the landmark study by Greenberg et al9, the studies that have directly 
compared the benefits of endovascular and open TAA repair22-27 are generally from single 
centres, have small sample sizes, and only two have examined data more recently than 
2007. Many studies group thoracic and thoracoabdominal aneurysms, limiting the 
application of these results. Thus, we sought to observe clinical outcomes of open and 
endovascular TAA repairs in two Australian tertiary-referral hospitals over the previous 
decade, examining ascending, arch, and descending aneurysms separately. We 
hypothesised that morbidity and mortality has decreased over the last decade, and that 
endovascular outperformed open TAA repair. 
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Materials & Methods 
A retrospective analysis of patient records was conducted at the Royal Prince Alfred and St 
George Hospitals, which are tertiary level acute-care hospitals in Sydney, Australia. 
International Classification of Diseases 10 classifications I71.1 (thoracic aortic aneurysm, 
ruptured), I71.2 (thoracic aortic aneurysm, without mention of rupture), I71.5 
(thoracoabdominal aneurysm, ruptured) and I71.6 (thoracoabdominal aortic aneurysm, 
without mention of rupture) were used to identify patients who presented with 
degenerative thoracic aortic aneurysms (including descending aneurysms of Crawford Class 
0-III1) between January 2003 and January 2013. Clinicopathologic manifestations included 
acute severe pain, chronic pain, acute rupture, and incidental findings. All treating surgeons 
were consultants, with 10 cardiothoracic and 11 vascular surgeons between the two 
hospitals. All vascular surgeons were skilled at both endovascular and open procedures. Due 
to the timeframe, the surgical teams and multidisciplinary teams varied across the study 
period.  
 
Demographic, surgical and clinical variables were collected. Independent variables included 
age, sex, year of intervention, aneurysm type (defined as above, with descending aneurysms 
classified as per 2010 Society for Vascular Surgery Reporting Standards28) and size, co-
morbidities, American Society of Anesthesiologists (ASA) score, presence of rupture, use of 
local or general anaesthetic, open or endovascular intervention, type and brand of graft, use 
of cardio-pulmonary bypass, and use of cerebrospinal fluid (CSF) drainage. Patients 
undergoing ascending aortic repair plus hemi-arch replacement were included in the 
ascending group, and not in the arch group. Patients with disease extending across multiple 
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areas of the aorta were excluded to prevent confounding. Patients who had undergone 
previous open debranching were considered as part of the endovascular group, as only an 
endovascular procedure was performed, and the open procedure was not performed during 
that admission. Patients undergoing hybrid repair were included in the endovascular group. 
Outcome variables included duration of surgical procedure, number of units of blood 
transfused, in-hospital complications, post-operative paraplegia (as previously described9), 
in-hospital mortality, presence of endoleaks, rates of return to theatre (within 24 hours) and 
re-operation (after the first 24 hours), acute kidney injury (defined as an increase in serum 
creatinine greater than fifty percent29) and acute kidney failure (defined as a tripling of 
serum creatinine29), time to first mobilisation, and duration of hospital and ICU (including 
coronary care unit) stay. Patients were also divided into two age groups (over and under the 
age of seventy-five years) to compare outcomes between younger and more elderly 
patients (seventy-five years was chosen as this has been previously found to be the median 
age of a high risk TAA-repair population5). Indication for CSF drainage was determined by 
the operating surgeon, with patients having undergone previous abdominal aortic aneurysm 
repair requiring pre-operative angiography to investigate spinal cord perfusion. 
 
Mann-Whitney U tests were used to assess differences between the medians of groups for 
continuous variables with skewed distributions, while t tests were used to compare means. 
Categorical variables were compared using Pearson Chi-squared Tests. Binomial tests were 
used to compare observed frequencies. Logistic regression was used to assess the 
relationship between independent and outcome variables, with Cox Regression to compare 
mortality rates of endovascular and open repairs, as well as baseline characteristics. A p 
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value of 0.05 was considered to be statistically significant. All analyses were performed 
using SPSS 22 (IBM, New York, New York, United States). 
 
Ethics approval was gained from the Human Research Ethics Committees at the University 
of Notre Dame Australia, with multi-centre ethics approval from the Sydney Local Health 
District Ethics Review Committee (RPAH Zone). Site specific ethics approval was gained from 
the Royal Prince Alfred and St George Hospitals separately. 
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Results 
 
Patients Undergoing Non-Surgical Management 
 
There were fifty-two patients with thoracic aneurysms that were managed without surgery 
(16 ascending, 24 arch, and 12 descending), due to a combination of surgery being deemed 
inappropriate due to age and comorbidities making survival unlikely, or patient refusal. Five 
of these patients presented with aneurysm rupture (1 ascending, 2 arch, and 2 descending). 
There was no difference in gender (p = 0.488).  Of the 8 patients that died in hospital 
(including all five ruptures), average time to mortality was 3 days, with 4 dying within 24 
hours of presentation. The ruptured aneurysms were not offered surgical intervention due 
to likely futility, based on presentation, age (all but one being over 85 years of age) and 
comorbidities. When compared to patients undergoing surgical management, patients 
managed conservatively were markedly older (64.4 ± 13.1 vs 73.9 ± 16.0 years, p <0.001), 
more likely to be female (31 vs 56%, p = 0.001), had shorter hospital stays (11.6 ± 13.6 vs 6.7 
± 10.2 days, p = 0.023), and were five-times more likely to die in hospital (3.1 vs 15.4%, p = 
0.002). There was no change in the non-operative rate over time. 
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Repair of Ascending Thoracic Aortic Aneurysms 
 
Sixty-nine patients underwent open repair of an ascending TAA, with an average age of 63.0 
± 12.5 years. Mean aneurysm size was 55.4 ± 10.6, with average ASA score 3.2 ± 0.6. 52.2% 
(36 patients) were smokers, 29.0% (20 patients) had ischemic heart disease, 58.0% (40 
patients) had hypertension, and 10.2% (7 patients) had diabetes. Patients were twice as 
likely to be male (66.7 vs 33.3%, p = 0.008). Average duration of surgery was 350 ± 101 
minutes, with mean duration of ICU stay 4.5 ± 6.0 days, and total hospital stay 11.6 ± 16.0 
days. 3 patients (4.4%) returned to theatre within 24 hours, and 3 patients (4.4%) 
underwent re-operation after the first day. An average of 2.9 ± 4.3 units of packed red cells 
were transfused, and mean time to mobilisation was 3.6 ± 7.5 days. One patient died, 
secondary to a cardiac arrest while in ICU. Of the 11 patients (15.9%) suffering cardiac 
complications, 9 patients suffered AF, and 4 suffered ventricular tachycardia (two of which 
responded to cardioversion, and two required internal cardiac massage). The 6 patients 
(8.7%) suffering infective complications included three with pneumonia, two with sepsis, 
and one with a sternotomy infection. Other complications included 3 respiratory (4.4%), 1 
renal (1.5%), 2 neurologic (2.9%), 4 haemorrhagic (5.8%), and 2 vaso-occlusive (2.9%). 
Patients over the age of 75 were no different to those under 75, in terms of baseline or 
outcome variables. 
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Arch Repairs 
Twenty-seven patients underwent arch aneurysm repair during the study period, twenty 
open and seven endovascular (with two of the seven being hybrid procedures). There was 
no difference in baseline characteristics and co-morbidities between these two groups 
(Table 2). Patients were four times more likely to be male (p = 0.006). Of the endovascular 
patients, one patient had undergone previous de-branching (left subclavian and carotid), 
two patients underwent hybrid repair, and the remaining four had their left subclavian 
covered (after appropriate pre-operative imaging). One patient had her endovascular repair 
under local anaesthetic, and one open patient required two grafts.  All open repairs were 
performed via sternotomy and received cardiopulmonary bypass (CPB). One endograft 
patient received CSF drainage, and one endograft patient did not go to ICU post-operatively.  
Causes for return to theatre in the endovascular group included a groin haematoma, and a 
broncho-aortic fistula. 
 
Duration of endovascular arch aneurysm repair was half as long as open repair (p = 0.0001), 
although there were no other differences in outcome between the two groups (Table 2). 
One patient suffered acute kidney injury (in the open group), one suffered a sternotomy 
wound infection, and seven of the patients developed atrial fibrillation. There were 2 
endoleaks (28.6%), one Type 1a, and one Type 1b. 
 
Patients over the age of 75 had significantly larger arch aneurysms (63.5 ± 8.7 vs 52.1 ± 
9.5mm, p = 0.035), were more likely to undergo an unplanned return to theatre (25.0 vs 
0.0%, p = 0.015), or develop an endoleak (25.0 vs 4.4% p = 0.048), despite no differences in 
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other baseline co-morbidities. There was also no difference in mortality nor complications 
when compared to patients under 75 years of age. Linear regression revealed no significant 
relationship between surgical duration or aneurysm size and outcome variables. There was 
no change in the percentage of endovascular arch procedures performed over the duration 
of the study period (Figure A1 – See Appendix), nor the rate of morbidity and mortality (p > 
0.05). 
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 Descending Repair 
Thirty-one patients underwent repair of descending aortic aneurysms, twelve open and 
nineteen endovascular. Three had undergone previous abdominal aortic aneurysm repair. 
There was no difference between rates of males and females undergoing descending repair 
(p = 0.071). Patients undergoing endografting were significantly older (75.6 ± 7.2 vs 55.9 ± 
17.2 years, p = 0.0001), but otherwise were no different regarding baseline characteristics 
and co-morbidities (Table 3). Three patients had undergone previous vascular debranching 
(one patient underwent re-implantation of a renal artery, and two patients underwent re-
implantation of mesenteric arteries), and four patients underwent hybrid repair (three 
required re-implantation of the left subclavian artery, one left subclavian and left carotid). 
Twenty-three patients required only one endograft, seven patients required two, and one 
patient required four. Four patients received grafts with fenestrations to the renal arteries 
bilaterally. In the open group, approaches included nine anterolateral thoracotomies, and 
three posterolateral thoracotomies. Six patients in the open group (50%), and six patients in 
the endovascular group (32%) underwent CSF drainage, with one open and two 
endovascular patients having had previous abdominal aortic aneurysm repair. 
 
Descending aneurysm endografting was a significantly shorter procedure, taking less than 
sixty-percent of the time of open repair (p = 0.003). There were no other differences in peri- 
and post-operative characteristics between the two groups (Table 3). There were six 
endoleaks in the endograft group, two Type 1a, one Type 1b, two Type 2, and one Type 3.  
Of the three endovascular patients requiring return to theatre, one was to exclude ischemic 
gut, one to treat an endoleak, and one due to groin haematoma. Three patients who 
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underwent descending aneurysm repair died (11%). There was one death from acute kidney 
failure, and two from sepsis. Acute renal failure occurred in two patients in the open group 
(one secondary to intravenous contrast), with acute kidney injury in one endograft patient. 
Linear regression revealed no significant relationship between aneurysm size nor surgical 
duration and outcome variables. Further, multivariable analysis with Cox regression 
revealed there was no difference in hazard of mortality for endovascular over open repair 
(Hazard Ratio of endovascular versus open repair 1.16, 95% CI 0.67 – 1.82, p = 0.83). 
Similarly, there was no relationship between age, aneurysm size, and comorbidities on 
morbidity (p>0.05). Two endovascular patients suffered paraplegia which resolved, one of 
whom had previous abdominal aortic aneurysm repair. 
 
Patients over the age of 75 were almost twice as likely to have an endovascular procedure 
(83.3 vs 47.4%, p = 0.045). They were also more likely to require more blood transfused (5.5 
± 9.7 vs 1.2 ± 1.9 units, p = 0.008), have a longer ICU stay (5.5 ± 9.7 vs 3.5 ± 2.2 days, p = 
0.032), non-ICU stay (10.1 ± 6.9 vs 6.1 ± 3.4, p = 0.003) and total hospital stay (14.1 ± 10.0 vs 
9.6 ± 4.0 days, p = 0.006).  
 
There was a significant increase in the percentage of endovascular descending aneurysm 
repairs over time (R2 = 0.453, β = 0.673, p = 0.033; Figure 1), but there was no change in 
rates of morbidity and mortality (p > 0.05). 
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Discussion 
While the total number of TAA repairs has increased in the United States over the last 2 
decades, the rate of open repair has remained constant30.  Endovascular repair rates now 
account for 31 percent of all repairs, and are likely to continue to rise30. In the current study, 
we found a similar trend for increasing endovascular repairs of descending aneurysms in 
Australia. This is likely due to the perceived high mortality rates of open repair31, the 
increasing acceptability of endovascular approaches, and the aging population making 
minimally invasive techniques more attractive. While one study demonstrated no 
difference32, it has been suggested that descending endovascular TAA repairs are less costly 
in the short term (despite the considerable expense of the endograft itself25, 33, 34). It is 
therefore possible that the increasing pressure to minimise health spending may be 
contributing to the increasing number of endovascular repairs, although there is evidence 
that endografting may become more expensive in the long term, due to surgeon follow up 
and CT surveillance25. However, new developments in endovascular technology, and 
potential decreases in endograft costs34 make endografting a viable option in an increasing 
proportion of patients. In fact, the most recent analysis of endovascular and open TAA 
repairs suggested that endovascular repair is more cost effective, notably as intervention 
rates post-operatively were less than expected35. This suggests that with time, endovascular 
repair is indeed becoming the more financially viable option.  The decrease in percentage of 
endovascular repairs between 2004 and 2006 is likely an artefact, due to the small total 
number of descending TAA repairs (two and three repairs in 2005 and 2006 respectively). 
37 
 
At the institutions examined in this study, we saw extremely low peri-operative mortality 
rates in patients undergoing thoracic aortic aneurysm repairs. Three percent of patients 
undergoing surgical management died during the study period, likely due to both improving 
technique, as well as careful patient selection (for example, non-operative patients were 
seen to be on average ten years older). However, patients over the age of 75 years were 
noted not to have a higher mortality rate, suggesting perhaps that endovascular repairs of 
descending TAAs may be appropriate in elderly patients, ones that may have been denied 
an operation previously – although it may be careful selection of patients in the current 
study that resulted in such outcomes. Interestingly, there was no difference in mortality 
rates nor complication rates between endovascular and open TAA repairs. In the current 
literature, data is conflicted regarding survival benefits and complication rates between 
open and endovascular approaches. The largest study to date from Greenberg et al 
demonstrated no difference in mortality either at one month or one year9, findings echoed 
by a Swiss study which saw no difference at one, twelve, twenty-four or thirty-six months24. 
Similarly, a study of US Medicare data between 1998 and 2007 demonstrated that while in 
the short term there may be a borderline mortality benefit from endovascular repair (6.1 vs 
7.1%, p = 0.07), this is lost by two years36. Several smaller studies concur, finding that a mild 
perioperative survival benefit is quickly lost, and remains absent at up to ten years22, 23, 25, 27, 
30. Overall, current evidence suggests no difference in long-term mortality between 
endovascular and open TAA repairs, with the mortality rate of the current study similar to 
that previously seen. 
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The comparative benefits of either open or endovascular techniques in minimising spinal 
cord ischemia also have not been seen, with only one study demonstrating a reduced risk of 
SCI in endovascular TAA repairs22.  In the current study, only two patients suffered 
paraplegia post-operatively, both of whom had undergone endografting of their descending 
aorta. The observed paraplegia rate of 8% post endografting is similar to the 3-7% seen in 
recent studies9, 22, 23, 25, 26, 37. This is interesting given that the use of spinal drains in our study 
institutions (at 50 and 32%) is much lower than previously observed, with up to 66 and 79% 
of patients undergoing prophylactic CSF drainage for open and endovascular repairs 
respectively25. Although a recent Cochrane analysis suggested that data is limited and needs 
further study38, the largest and most recent randomised controlled trial39 found CSF 
drainage is effective in preventing SCI. As such, further randomised controlled trials into the 
efficacy of CSF drainage in preventing spinal cord ischemia are required. 
 
No difference was seen in complication rate, when comparing open and endovascular 
thoracoabdominal aneurysm repair. Although not statistically significant, patients 
undergoing endovascular descending TAA repair were seen to suffer more paraplegic and 
infectious complications, but the numbers of patients suffering these complications being 
small makes this difficult to interpret. While not demonstrated in this study, endovascular 
approaches have generally been shown to decrease the incidence of renal failure22, 25, 27, 
respiratory failure22, duration of ICU25, 27, 37 and hospital stays22, 37, and rates of reoperation9, 
27.  However, with endovascular interventions there is the added risk of endoleaks22 and 
peripheral vascular complications22, with evidence for increased cost25, 27. Interestingly, 
patients who underwent endovascular TAA repair reported being significantly more 
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depressed, and scored lower than a healthy cohort on subjective physical and mental 
domain scores, while the open repair group scored within the normal range24.  
 
The difficulty with such studies is that sicker and more elderly patients are more likely to 
receive endovascular TAA repair9, 23-25, thus skewing outcomes. In fact, the current study 
demonstrated that patients undergoing endovascular repair were on average five and 
twenty years older for arch and descending aneurysm repairs respectively. However, a large 
meta-analysis (which included repairs of aortic trauma, dissections, ulcers and intra-mural 
haemorrhage) by Cheng et al and included 5,888 patients demonstrated that age did not 
impact outcomes when considering mortality, cerebrovascular accidents and paraplegia40. 
Similarly, we found that although patients over the age of seventy-five years were more 
likely to undergo endovascular interventions, there was no difference in peri-operative 
mortality, likely due to appropriate patient selection, and pre-operative planning and 
assessment. However, these patients were more likely to return to theatre within 24 hours, 
suffer endoleaks, have a higher transfusion requirement, and have a longer hospital and ICU 
stay, despite no differences in baseline comorbidities. While patients over 75 years had 
larger arch aneurysms than those under 75, size of aneurysm was found not to correlate 
with peri- and post-operative outcome. These findings suggest that while surgical repair of 
TAAs in elderly patients is likely to carry a low burden of mortality, these patients are at 
increased risk of post-operative complications. 
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The key limitations of this study are its retrospective nature, and its small sample sizes. 
Sample size is notably an issue for endovascular treatment of arch and descending 
aneurysms, notably as ICU stay appears to be (non-significantly) greater for endovascular 
than open repairs. Additionally, as the endovascular group includes patients who underwent 
hybrid procedures, their duration of stay and complication rate were not likely to differ from 
open repairs. As such, a more accurate comparison of endovascular and open repairs would 
contrast open and pure endovascular repairs, with no open procedures. Due to the relative 
rarity of thoracic aneurysms, sample sizes remain small, and studies are universally 
retrospective. As a result, it is difficult to make conclusive decisions regarding optimal 
surgical management from such studies. In fact, a 2009 Cochrane review has called for 
randomised controlled trials on TAA repairs to definitively address the endovascular versus 
open query41. 
 
In conclusion, surgical repair of thoracic aortic aneurysms in carefully selected patients in 
Australia is associated with minimal mortality, but considerable morbidity. Apart from a 
reduced surgical duration, the present study revealed no benefits of endovascular over 
open TAA repair, with economic factors possibly driving the increasing proportion of 
descending endografts seen. Overall, endovascular repair continues to perform well, 
especially in high-risk and elderly patients, and should be considered intervention of choice 
in suitable patients. Elderly patients are at increased risk of complications, but appropriate 
patient selection and preoperative planning make TAA repair a valid option in increasingly 
elderly and frail patients. 
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Tables 
 
Table 1 – Characteristics for all thoracic aneurysm patients, with comparisons between those 
who underwent conservative and surgical management. Results are presented as means 
with standard deviations. Categorical variables are expressed as raw number, with 
percentage of the total in brackets. *p > 0.05 
 
 Total Conservative Surgical P Value 
Number 179 52 127 - 
Age (years) 67.2 ±14.6 73.9 ± 16.0 64.4 ± 13.1 <0.001* 
Male Gender (%) 111 (62.0%) 23 (44%) 88 (69.3%) 0.001* 
Aneurysm Type     
      Ascending (%) 93 (52.0%) 24 (46.2%) 69 (54.3%) 0.542 
      Arch (%) 43 (24.0%) 16 (30.8%) 27 (21.3%) 0.072 
      Descending (%) 41 (22.9%) 10 (19.2%) 31 (24.4%) 0.618 
       Unknown (%) 2 (1.1%) 2 (3.8%) 0 (0.0%) - 
Aneurysm size (mm) 57.7 ± 14.6 60.2 ± 15.5 56.6 ± 14.1 0.114 
Smoking status (%) 87 (48.6%) 15 (28.9%) 72 (56.6%) <0.001* 
Ischemic heart disease (%) 60 (33.5%) 20 (38.4%) 40 (31.5%) 0.379 
Hypertension (%) 123 (68.7%) 39 (75.0%) 83 (65.4%) 0.148 
Diabetes (%) 22 (12.3%) 7 (13.5%) 15 (11.8%) 1.000 
In-hospital Mortality (n) 12 (6.7%) 8 (15.4%) 4 (3.1%) 0.002* 
Duration of Hospital Stay 
(Days) 
10.2 ± 12.8 6.7 ± 10.2 11.6 ± 13.6 0.023* 
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Table 2 – Baseline, peri- and post-operative characteristics for patients undergoing arch 
aneurysm repair. Results are presented as means with standard deviations. Categorical 
variables are expressed as raw number, with percentage of the total in brackets. *p < 0.05. 
€Excluding pneumonia, which has been classified as ‘Infectious’. £Excluding 
paraplegia/paraparesis. 
 Total Open Repair Endovascular 
Repair 
p value 
Number 27 20 7 - 
Age (years) 64.1 ± 11.4 62.9 ± 11.0 67.7 ± 12.8 0.363 
Male gender (%) 21 (77.8%) 16 (80.0%) 5 (71.4%) 0.639 
Aneurysm size (mm) 53.0 ± 10.1 52.7 ± 10.9 58.2 ± 6.4 0.083 
Smoking status (%) 13 (48.2%) 9 (45.0%) 4 (57.1%) 0.580 
Ischemic heart disease (%) 9 (33.3%) 6 (30.0%) 3 (32.9%) 0.535 
Hypertension (%) 22 (81.5%) 15 (75.0%) 7 (100%) 0.143 
Diabetes (%) 6 (22.2%) 5 (25.0%) 1 (14.3%) 0.557 
ASA Score 3 ± 0.6 3.1 ± 0.5 2.8 ± 0.8 0.413 
Duration of Surgery (min) 343 ± 134 396 ± 98 193 ± 108 <0.000* 
Return to theatre within 24hrs (%) 1 (3.7%) 0 (0.0%) 1 (14.3%) 0.085 
Re-operation (%) 2 (7.4%) 1 (5.0%) 1 (14.3%) 0.419 
In-hospital Mortality (%) 0 (0%) 0 (0%) 0 (0%) - 
Complications (%) 18 12 6 0.850 
Respiratory€ 0 (0%) 0 (0%) 0 (0%) - 
Renal 1 (3.7%) 1 (5.0%) 0 (0%) 0.850 
Paraplegia/paraparesis 0 (0%) 0 (0%) 0 (0%) - 
Cardiac 9 (33.3%) 7 2 (28.6%) 0.808 
Infectious 3 (11.1%) 2 1 (14.3%) 0.893 
Neurologic£ 1 (3.7%) 0 (0%) 1 (14.3%) 0.607 
Vaso-occlusive 0 (0%) 0 (0%) 0 (0%) - 
Haemorrhagic 3 (11.1%) 2 (10.0%) 2 (28.6%) 0.498 
Units of Blood Transfused 2.88 ± 4.2 3.45 ± 2.1 1.3 ± 2.2 0.162 
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Table 2 continued 
Endoleaks     
Type I (%) 2 (7.4%) - 2 (28.6%) - 
Type II (%) 0 - 0 - 
Duration of ICU Stay  (days) 4.5 ± 6.9 3.45 ± 2.11 7.4 ± 13.3 0.464 
Time to First Mobilisation (days) 3.2 ± 8.0 1.75 ± 1.1 7.3 ± 15.8 0.978 
Duration of Non-ICU Stay (days) 7.2 ± 11.3 6.25 ± 4.0 8.4 ±10.5 0.850 
Total Duration of Hospital Stay 
(days) 
11.3 ± 12.3 9.7 ± 4.6 15.9 ± 23.6 0.341 
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Table 3 – Baseline, peri- and post-operative characteristics for patients undergoing 
descending aneurysm repair. Results are presented as means with standard deviations. 
Categorical variables are expressed as raw number, with percentage of the total in brackets. 
*p <0.05. €Excluding pneumonia, which has been classified as ‘Infectious’. £Excluding 
paraplegia/paraparesis.  
 
 Total Open Repair Endovascular 
Repair 
p value 
Number (n) 31 12 19 - 
Age 68.0 ± 15.33 55.9 ± 17.2 75.6 ± 7.2 <0.005* 
Male gender (%) 21 (67.7%) 7 (58.3%) 14 (73.7%) 0.373 
Aneurysm size (mm) 62.8 ± 22.2 66.3 ± 21.4 59.6 ± 23.3 0.461 
Smoking status (%) 23 (74.2%) 8 (66.7%) 15 (79.0%) 0.447 
Ischemic heart disease (%) 11 (35.5%) 3 (25.0%) 8 (42.1%) 0.332 
Hypertension (%) 21 (67.7%) 7 (58.3%) 14 (73.7%) 0.373 
Diabetes (%) 2 (6.5%) 0 (0%) 2 (10.5%) 0.245 
ASA Score 3.4 ± 0.7 3.8 ± 0.7 3.3 ± 0.7 0.079 
Crawford Classification      
      0 (%) 6 (19.4%) 2 (16.7%) 4 (21.1%) 0.763 
      I (%) 21 (67.7%) 9 (75.0%) 12 (63.2%) 0.492 
      II (%) 2 (6.5%) 0 (0%) 2 (10.5%) 0.245 
      III (%) 2 (6.5%) 1 (8.3%) 1 (5.3%) 0.735 
Duration of Surgery (min) 311 ± 160 422.5 ± 161 242 ± 116 0.003* 
Return to theatre within 24hrs 
(%) 
4 (12.9%) 3 (25%) 1 (5.3%) 0.110 
Re-operation (%) 4 (12.9%) 2 (16.7%) 2 (10.5%) 0.619 
In-hospital Mortality (%) 3 (9.7%) 1 (8.3%) 2 (10.5%) 0.841 
 
  
53 
 
Table 3 continued 
 Total Open Repair Endovascular 
Repair 
p value 
Complications (total) 23 9 14 0.330 
      Respiratory€ (%) 9 (29.0%) 4 (33.3%) 5 (26.3%) 0.218 
      Renal (%) 3 (9.7%) 2 (16.7%) 1 (5.3%) 0.296 
      Paraplegia/ 
     paraparesis (%) 
2 (6.5%) 0 (0%) 2 (10.5%) 0.245 
      Cardiac (%) 1 (3.2%) 0 (0%) 1 (5.3%) 0.419 
      Infectious (%) 4 (12.9%) 0 (0%) 4 (21.1%) 0.089 
      Neurologic£ (%) 2 (6.5%) 1 (8.3%) 1 (5.3%) 0.735 
      Vaso-occlusive (%) 0 (0.0%) 0 (0%) 0 (0%) - 
      Haemorrhagic (%) 2 (6.5%) 2 (16.7%) 0 (0%) 0.066 
Units of Blood Transfused 2.9 ± 5.5 3.9 ± 7.6 2.2 ± 3.7 0.704 
      Type I 3 (9.7%) - 3 (15.8%) - 
      Type II 2 (6.5%) - 2 (10.5%) - 
      Type III 1 (3.2%) - 1 (5.3%) - 
Duration of ICU Stay  (days) 4.3 ± 6.2 3.9 ± 3.0 4.5 ± 7.6 0.562 
Time to First Mobilisation (days) 2.8 ± 1.9 3.7 ± 2.2 2.4 ± 1.5 0.100 
Duration of Non-ICU stay (days) 7.5 ± 5.4 8.8 ± 5.2 6.9 ± 5.5 0.177 
Duration of Hospital Stay (days) 11.9 ± 7.9 12.7 ± 6.9 11.5 ± 8.6 0.389 
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Figure 
 
Figure 1 – Percentage of patients undergoing endovascular descending aneurysm repair per 
year over the study period. R2 = 0.453, β = 0.673, p = 0.033 
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Conclusion 
 
Thoracic and thoracoabdominal aneurysms continue to carry a significant burden of disease, 
and while medical management is appropriate for patients with smaller aneurysms, surgical 
intervention is indicated for patients with aortic diameters of greater than 5 - 5.5 
centimetres. Once the mainstay of definitive treatment, open surgical management has long 
been associated with significant morbidity and mortality given the extent and location of the 
pathology.  Endovascular repair is accepted as the optimal method of management for 
many vascular diseases, but clinical equipoise remains in thoracic and thoracoabdominal 
aneurysm repairs, due to a lack of evidence. It is possible that this is analogous to 
endovascular versus open repairs of abdominal aortic aneurysms, where the first trials 
(notably the landmark EVAR-1 trial50), suggested that equipoise persisted, although 
subsequent studies have demonstrated that endovascular AAA repair is the gold standard, 
for both ruptured and intact AAAs31,51. As such, it is possible that the relatively young 
technology of endovascular thoracic aneurysm repair is merely awaiting sufficient evidence 
before its use can be considered to be either superior or inferior to open repair. 
 
In attempting to contribute to the current body of knowledge, this two-centre study 
demonstrated that although endovascular repairs markedly reduced surgical duration, no 
other benefits in morbidity or mortality were seen. This agrees with the current literature 
suggesting that while there may be a mild short-term benefit (if any), this is quickly lost.  
Current thinking in abdominal aortic aneurysm repairs is that open repair may be the 
optimal method of surgical management in young, low risk patients, given the reduced need 
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for re-intervention in the long term52. Similarly, while endovascular repairs demonstrate 
some mild short-term benefits such as that seen in the current study, this may be offset by 
long-term endograft complications such as endoleaks and graft migration, and open surgery 
may remain the mainstay of treatment in low risk patients. In addition, with open repairs 
being less costly in the long term, this may be the more viable financial option. However, 
hybrid and debranching procedures added minimal morbidity and had no impact on 
mortality, suggesting these are likely to play an increasing role. 
 
A comparatively low mortality rate was observed across all repairs, both open and 
endovascular, suggesting TAA repair is a relatively safe procedure despite patients being 
highly comorbid. This is likely due to both improvements in technique and technology, as 
well as careful patient selection, with conservatively-managed patients over a decade older 
on average. There is also likely a selection bias which cannot be understated. Planning of a 
thoracic aneurysm repair, whether open or endovascular, is a complex process, and patients 
are rarely suitable for both (due to patient comorbidity, or aneurysm morphology). As such, 
it is difficult to compare open and endovascular TAA repairs head-to-head, as in the clinical 
setting it is not simply a case of “either-or”. Given the complex nature of the pathology, it is 
likely that endovascular management will continue to be chosen in patients with amenable 
aortic anatomy, given the possible reduction in short term risk. 
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As has been observed in the United States38, we demonstrated a trend for increasing 
endovascular repair of descending TAAs in Australia, although there was no change in 
morbidity nor mortality over the study period. Further, the rate of paraplegia post 
endografting was comparable to similar studies despite a low rate of cerebrospinal fluid 
drainage, demonstrating that the role of CSF drainage in endovascular TAA repairs remains 
unclear. 
 
Elderly patients were noted to be at increased risk of complications, have a higher 
transfusion requirement and length of hospital stay than younger patients. However, 
appropriate patient selection and preoperative planning make both open and endovascular 
repair a valid option in increasingly elderly patients, with endovascular repair performing 
well in these high-risk patients. 
 
In order to definitively establish the comparative efficacy of endovascular and open repairs 
of thoracic aortic aneurysms, large randomised controlled trials are needed. These should 
be conducted with a method similar to the landmark DREAM trial that compared 
endovascular and open repair of abdominal aortic aneurysms48, and a similar protocol for 
long term follow up. However, as discussed above, the complex nature of thoracic and 
thoracoabdominal aneurysms make head-to-head comparisons difficult, as randomisation 
would have to be carefully considered given aneurysm morphologies. Further, given the 
relative scarcity of thoracoabdominal aneurysms, it would be difficult to generate significant 
numbers for such a study. 
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In summary, this study demonstrated low mortality in both endovascular and open thoracic 
aneurysm repair, but with considerable morbidity. As there was no difference seen between 
open and endovascular approaches, either option is suitable in appropriately selected 
patients. However, further studies are needed to elucidate the optimal management of 
thoracoabdominal aneurysms. 
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B. Purpose of Request 
 What are the anticipated start and end dates for the research? 
 
Data collection is to commence upon ethics approval, likely late July 2013, and be 
completed by late December 2013. Data analysis will begin December 2013, to be 
completed by January 2014. Construction of the introduction (including background and 
rationale) and methods section of the manuscript was commenced in February 2013, and 
writing of the results and discussion section will begin in January 2014, to be completed by 
March 2014. 
 
How will the research benefit patients and contribute to healthcare, now or in the future? 
 
The findings will compare the clinical outcomes of open and endovascular TAAA repairs in 
two large hospitals. It will be one of the largest studies of its kind to date internationally, the 
first multi-centre study, and the first undertaken in an Australian setting. The study will 
illustrate the clinical and economic feasibility of the two techniques, demonstrating the 
optimal method of management of TAAAs, as well as illustrating improvements in 
management of this condition over time, and providing direction for future service planning 
in Australia. 
 
How will outcomes be measured? 
 
International Classification of Diseases version 10 classification I71.6 (thoracoabdominal 
aortic aneurysm, without mention of rupture) will be used to identify patients diagnosed 
with thoracoabdominal aortic aneurysm (Crawford Class I-III), and inclusion and exclusion 
criteria similar to those used in the DREAM trial on AAAs of 2010 will be applied. Various 
demographic, surgical and clinical variables will be collected from patient records by 
research assistants who will de-identify the data before it is seen by the principal 
investigators. The research assistants are medical students from the University of Notre 
Dame, and will be paid for their time. Independent variables will include age, sex, year of 
intervention, Crawford class, co-morbidities, pre-operative creatinine, open or endovascular 
intervention, type of graft and circulatory adjuncts used, and use of cerebrospinal fluid 
drainage. Outcome variables will include in-hospital complications, post-operative 
paraplegia, in-hospital mortality, duration of surgical procedure, contrast dose, radiographic 
screening time, blood loss, re-operation rates, time to first mobilisation, post-operative 
creatinine, and duration of hospital stay. In-patient cost will be estimated using the 
respective costs of the open and endovascular grafts. 
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What deliverables and milestones will there be? How will progress be reported? 
 
Preliminary analyses will be performed on completion of the data (December 2013), with 
the final results to be submitted as a manuscript (to the journal Circulation) in March 2014. 
 
Does the research involve human subjects? 
 
Yes, but not directly, as data is being collected from paper medical records, and no patients 
will be contacted. 
 
Does the research involve Cook product(s)? Explain: 
 
Yes. Cook is one of the types of endograft used in repair of thoracoabdominal aortic 
aneurysms in the study hospitals, and so will be one of the types of graft included in the 
analysis. 
 
If known, check the relevant therapeutic or diagnostic area: 
 
Aortic Intervention 
Critical Care 
Endoscopy 
Interventional Radiology 
Cardiac Lead Management 
Surgery 
Urology 
Peripheral Intervention 
Women's Health 
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C. Product and/or Funding Request 
 
 What product(s) are you requesting from Cook? (Include product name, quantity, and 
global product number, if known). If, at Cook's sole discretion, an item is unavailable for 
donation, please list an acceptable substitute: 
 
Nil 
 
Amount of funding requested from Cook (please indicate type of currency): 
 
$3,000 AUD. This includes $1,250 for each of the two students (50 hours of data collection, 
at $25 AUD per hour) to a total of $2,500, and $500 for the fee of retrieval of medical 
records from off-site storage at St George Hospital. 
 
Total amount of funding needed to complete the project: 
 
$3,000 AUD. 
 
Are other commercial sponsors being secured for the event? 
 
No 
 
Check Information 
Check made payable to: The School of Medicine. University of Notre Dame, Sydney 
 
Mail check to: 
160 Oxford St, Darlinghurst, NSW, 2010 
Checks cannot be processed without receipt of a signed W-9 Tax Form (U.S. only) 
 Wire transfer information: N/A 
Account Name: Bank Name: N/A 
Account Number: Bank Location (U.S. - City/State International - City/Country) N/A 
Bank Identifier Code (Swift code): Routing Number (IBAN # or ABA #): N/A 
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D. Verification 
 This request for funding was completed by the undersigned, who certifies to the accuracy 
of the information provided: 
 
Name: Edward Waters 
  
Date: 9/7/13 
 
Email address: edward.waters@nd.edu.au 
 
E. Submission 
 Please direct the completed form, attachments and any questions to the appropriate Cook 
Donation Review Team administrator. 
 
Asia Pacific 
(APAC) 
_________________________________ 
grantsapac@cookmedical.com 
Fax: +61 7 3341 3841 
 Phone: +61 7 3841 1188 
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Appendix 4: Approval Letter from Cook Medical for Research Funding 
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Appendix 4: Additional Figure 
 
Figure A1 – Percentage of patients undergoing endovascular arch aneurysm repair per year 
over the study period. R2 = 0.19, p = 0.89 
 
 
